AMBER BARRON: Open Payments
NPI 1124535596 · PENNINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 65 payments from 19 companies in 2025. Trend: 2023 $118 · 2024 $962 · 2025 $1,470
Food & beverage: $1,470
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 21 | $310 |
| HEARTFLOW, INC. | 3 | $155 |
| Alnylam Pharmaceuticals Inc. | 3 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| Novo Nordisk Inc | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| SCPHARMACEUTICALS INC. | 3 | $90 |
| Biosense Webster, Inc. | 3 | $85 |
| Ionis Pharmaceuticals, Inc. | 2 | $65 |
| CVRx, Inc. | 3 | $64 |
Products named: LifeVest, FFRct, AMVUTTRA, LEQVIO, LOKELMA, FUROSCIX, CARTO 3, Wegovy.
Industry payments across NJ — which companies pay providers there.
